Compositions and their uses directed to huntingtin
AssigneeIsis Pharmaceuticals, Inc.
InventorSusan M. Freier
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's Disease (HD) progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntington's Disease (HD) in an individual susceptible to Huntington's Disease (HD). Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
Claims21
An antisense oligonucleotide 12 to 35 nucleotides in length comprising at least 12 consecutive nucleotides having at least 90% complementarity to nucleotides 5801-5820 of SEQ ID NO:
- 4.
-20. (canceled)
Dependencies are inferred from the claim text.